'SNO'-Storms Compromise Protein Activity and Mitochondrial Metabolism in Neurodegenerative Disorders

被引:45
|
作者
Nakamura, Tomohiro [1 ,2 ,3 ,4 ]
Lipton, Stuart A. [1 ,2 ,3 ,4 ,5 ]
机构
[1] Scripps Res Inst, Neurosci Translat Ctr, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Dept Neurosci, La Jolla, CA 92037 USA
[4] Scintillon Inst, Neurodegenerat Dis Ctr, San Diego, CA 92121 USA
[5] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA
来源
关键词
NADP(+)-DEPENDENT ISOCITRATE DEHYDROGENASE; BRAIN ENERGY-METABOLISM; CYTOCHROME-C-OXIDASE; NITRIC-OXIDE; S-NITROSYLATION; COMPLEX-I; CELL-DEATH; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PERSISTENT INHIBITION; PARKINSONS-DISEASE;
D O I
10.1016/j.tem.2017.10.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), is currently a major public health concern due to the lack of efficient disease-modifying therapeutic options. Recent evidence suggests that mitochondrial dysfunction and nitrosative/oxidative stress are key common mediators of pathogenesis. In this review, we highlight molecular mechanisms linking NO-dependent post-translational modifications, such as cysteine S-nitrosylation and tyrosine nitration, to abnormal mitochondrial metabolism. We further discuss the hypothesis that pathological levels of NO compromise brain energy metabolism via aberrant S-nitrosylation of key enzymes in the tricarboxylic acid (TCA) cycle and oxidative phosphorylation, contributing to neurodegenerative conditions. A better understanding of these pathophysiological events may provide a potential pathway for designing novel therapeutics to ameliorate neurodegenerative disorders.
引用
收藏
页码:879 / 892
页数:14
相关论文
共 50 条
  • [31] The role of the prion protein in neurodegenerative disorders
    De Mario, A.
    Peggion, C.
    Bertoli, A.
    Massimino, M.
    Sorgato, M. C.
    FEBS JOURNAL, 2013, 280 : 434 - 434
  • [32] The prion protein in human neurodegenerative disorders
    Kovacs, GG
    Zerbi, P
    Voigtländer, T
    Strohschneider, M
    Trabattoni, G
    Hainfellner, JA
    Budka, H
    NEUROSCIENCE LETTERS, 2002, 329 (03) : 269 - 272
  • [33] Neurodegenerative Eye Disorders: Role of Mitochondrial Dynamics and Genomics
    Mohanty, Kuldeep
    Dada, Rima
    Dada, Tanuj
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2016, 5 (04): : 293 - 299
  • [34] Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?
    van Horssen, Jack
    van Schaik, Pauline
    Witte, Maarten
    NEUROSCIENCE LETTERS, 2019, 710
  • [35] New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
    Wilkins, Heather M.
    Morris, Jill K.
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (05) : 731 - 752
  • [36] The therapeutic potential of mitochondrial transplantation for the treatment of neurodegenerative disorders
    Espino De la Fuente-Munoz, Cesar
    Arias, Clorinda
    REVIEWS IN THE NEUROSCIENCES, 2021, 32 (02) : 203 - 217
  • [37] Mitochondrial SIRT3 and neurodegenerative brain disorders
    Anamika
    Khanna, Archita
    Acharjee, Papia
    Acharjee, Arup
    Trigun, Surendra Kumar
    JOURNAL OF CHEMICAL NEUROANATOMY, 2019, 95 : 43 - 53
  • [38] Mitochondrial iron homeostasis and its dysfunctions in neurodegenerative disorders
    Mena, Natalia P.
    Urrutia, Pamela J.
    Lourido, Fernanda
    Carrasco, Carlos M.
    Nunez, Marco T.
    MITOCHONDRION, 2015, 21 : 92 - 105
  • [39] Therapeutic modulation of mitochondrial dynamics by agmatine in neurodegenerative disorders
    Nibrad, Dhanshree
    Shiwal, Amit
    Tadas, Manasi
    Katariya, Raj
    Kale, Mayur
    Kotagale, Nandkishor
    Umekar, Milind
    Taksande, Brijesh
    NEUROSCIENCE, 2025, 569 : 43 - 57
  • [40] Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation
    Mantle, David
    Hargreaves, Iain Parry
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)